Intranasal SB-705498 in Allergic Rhinitis (AR) Patients

NCT01424397 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinitis

Interventions

DRUG: SB-705498
DRUG: FP
DRUG: placebo

Sponsor

GlaxoSmithKline